Importantly, the analysis of the TP53 pathway revealed that both ATM and TP53 are somatically mutated in a significant proportion of diffuse large B-cell lymphoma (DLBCL) cases, approximately 20%, regardless of the genetic subtype. Here, ATM is linked to diffuse large B-cell lymphoma.